Commentary: antibodies reacting with the infliximab Fab portion--something new? Authors' reply.

Saved in:
Bibliographic Details
Title: Commentary: antibodies reacting with the infliximab Fab portion--something new? Authors' reply.
Authors: Nielsen CH; Department of Infectious Diseases and Rheumatology, Institute for Inflammation Research, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Claus.Henrik.Nielsen@regionh.dk, Steenholdt C, Palarasah Y, Bendtzen K, Teisner A, Brynskov J, Teisner B
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2013 Sep; Vol. 38 (5), pp. 552-3.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.12426